Biodexa Pharma Surges 62% On Positive Data Of ERapa Familial Adenomatous Polyposis

Shares of Biodexa Pharmaceuticals Plc (BDRX) surged over 62% on Tuesday morning on positive data of eRapa in Familial Adenomatous Polyposis. BDRX is currently trading at $2.

Related Keywords

Washington ,United States ,Texas , ,Biodexa Pharmaceuticals Plc ,Nasdaq ,Research Institute Of Texas ,Familial Adenomatous ,Familial Adenomatous Polyposis ,Disease Week ,Cancer Prevention ,Research Institute ,